Search
for
Sort by
Research 871–900 of 1000+
- Nutrition and the deleterious side effects of nutritional supplements
- Alopecia Areata
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- AMINOPTERIN IN TREATMENT OF LEUKEMIA IN CHILDREN
- Pediatric Psychocutaneous Disorders
- First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II study
- Androgenic effects of oral contraceptives: Implications for patient compliance
- THALLIUM POISONING
- Comorbid conditions in lichen planopilaris: A retrospective data analysis of 334 patients
- The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia
- Comparison of Zn, Cu, and Fe Content in Hair and Serum in Alopecia Areata Patients with Normal Group
- Polycystic Ovary Syndrome: A Common Reproductive and Metabolic Disorder Necessitating Early Recognition and Treatment
- Clinical Approach to the Patient With Alopecia
- An Update on Drug-Induced Pigmentation
- Psychosomatic aspects of alopecia areata
- Female Adolescent Hair Disorders
- Secondary cicatricial and other permanent alopecias
- Alopecia in Children: The Most Common Causes
- Inhibiting the cytosolic function of CXXC5 accelerates diabetic wound healing by enhancing angiogenesis and skin repair
- Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
- Systemic causes of hair loss
- Standardizing the 60-Second Hair Count
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Melatonin-Loaded Nanocarriers: New Horizons for Therapeutic Applications
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies
- Kawasaki disease: an update
- Mason gastric bypass
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters